Testing gene therapy for Parkinson's disease

US researchers at Cornell University in New York have conducted a first trial of gene therapy in 11 Parkinson's patients and have achieved encouraging results.

Neurons of normal people and people with Parkinson's disease (right) .

Two physicians Michael Kaplitt and Matthew During led the study that injected into the nucleus of the hypothalamus - pituitary of patients with a solution containing GABA-producing genes, neurotransmitters that inhibit the activity of god cells. menstruation to reduce symptoms of Parkinson's disease.

Testing in people who are in this stage of developmental disease to check the harmlessness of therapy. One year after the injection, no patients had side effects. The researchers claim that this therapy is effective despite not being high. They have based their tests on mice.

The purpose of therapy is to reduce the disruptive activity of nerve cells that control muscle movement and reduce abnormal movements of patients.

NS